eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | renal cell carcinoma |
| Symptom | C0153690|bone metastases |
| Sentences | 7 |
| PubMedID- 25651794 | bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis. |
| PubMedID- 20937648 | Background: the aim of our study was to determine whether the presence of bone metastases affects outcomes in patients with metastatic clear-cell renal cell carcinoma (m-ccrcc) receiving sunitinib. |
| PubMedID- 23132391 | Background: the presence of bone metastases in patients with metastatic renal cell carcinoma treated with oral tyrosine kinase inhibitors (tkis) is associated with poorer outcome as compared with patients without bone involvement. |
| PubMedID- 24731497 | Objective: to retrospectively analyze the survival of renal cell carcinoma patients with bone metastases, evaluate the effect of treatment and identify the prognostic factors in these patients. |
| PubMedID- 22965827 | However, it remains unclear whether bisphosphonates improve overall survival (os) for renal cell carcinoma (rcc) patients with bone metastases. |
| PubMedID- 24063967 | Background: surgery remains the main treatment of bone metastases due to renal cell carcinoma (rcc). |
| PubMedID- 20809091 | Background: the use of zoledronic acid (zol) has recently been shown to significantly reduce the risk of new skeletal-related events (sres) in renal cell carcinoma (rcc) patients with bone metastases. |
Page: 1